DE69127549T2 - 5h-dibenzo[a,d]cycloheptene als muscarinic-rezeptor-antagonist - Google Patents

5h-dibenzo[a,d]cycloheptene als muscarinic-rezeptor-antagonist

Info

Publication number
DE69127549T2
DE69127549T2 DE69127549T DE69127549T DE69127549T2 DE 69127549 T2 DE69127549 T2 DE 69127549T2 DE 69127549 T DE69127549 T DE 69127549T DE 69127549 T DE69127549 T DE 69127549T DE 69127549 T2 DE69127549 T2 DE 69127549T2
Authority
DE
Germany
Prior art keywords
cycloheptene
dibenzo
receptor antagonist
muscarinic receptor
muscarinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69127549T
Other languages
English (en)
Other versions
DE69127549D1 (de
Inventor
Marcel Domaine Des Gran Hibert
Hijfte Luc Van
Mary Richards
Paul Moser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69127549D1 publication Critical patent/DE69127549D1/de
Application granted granted Critical
Publication of DE69127549T2 publication Critical patent/DE69127549T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/31—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings
    • C07C211/32—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings containing dibenzocycloheptane or dibenzocycloheptene ring systems or condensed derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69127549T 1990-05-18 1991-04-25 5h-dibenzo[a,d]cycloheptene als muscarinic-rezeptor-antagonist Expired - Lifetime DE69127549T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90401332 1990-05-18
PCT/US1991/002914 WO1991017973A1 (en) 1990-05-18 1991-04-25 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS

Publications (2)

Publication Number Publication Date
DE69127549D1 DE69127549D1 (de) 1997-10-09
DE69127549T2 true DE69127549T2 (de) 1998-04-23

Family

ID=8205710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69127549T Expired - Lifetime DE69127549T2 (de) 1990-05-18 1991-04-25 5h-dibenzo[a,d]cycloheptene als muscarinic-rezeptor-antagonist

Country Status (6)

Country Link
EP (1) EP0581767B1 (de)
JP (1) JPH05508399A (de)
AU (1) AU7957191A (de)
DE (1) DE69127549T2 (de)
ES (1) ES2109268T3 (de)
WO (1) WO1991017973A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508280A (en) * 1990-05-18 1996-04-16 Merrell Pharmaceuticals, Inc. 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness
KR100700440B1 (ko) 2005-01-14 2007-03-27 네오뷰코오롱 주식회사 청색 발광 유기 화합물 및 이를 포함하는 유기 발광다이오드

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA958643A (en) * 1970-07-07 1974-12-03 Frosst (Charles E.) And Co. Pharmaceutical compositions containing cyclobenzaprine
US3828034A (en) * 1972-05-25 1974-08-06 Syntex Inc Tricyclic pharmacological agents,intermediates and methods of making
ES8502099A1 (es) * 1983-08-02 1984-12-16 Espanola Farma Therapeut Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.

Also Published As

Publication number Publication date
AU7957191A (en) 1991-12-10
JPH05508399A (ja) 1993-11-25
EP0581767B1 (de) 1997-09-03
ES2109268T3 (es) 1998-01-16
WO1991017973A1 (en) 1991-11-28
DE69127549D1 (de) 1997-10-09
EP0581767A1 (de) 1994-02-09

Similar Documents

Publication Publication Date Title
GB9020051D0 (en) Muscarinic receptor antagonists
EP0687472A3 (de) Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
EP0714663A3 (de) Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
DE69830409D1 (de) 4-aminopyrrole[3,2-d]pyrimidine als neuropeptid rezeptor antagonisten
DE69203955D1 (de) Benzazepinderivate als Vasopressin-Antagonisten.
ATE226578T1 (de) Benzofuranderivate als tachykininantagonisten
DE69207351T2 (de) Fibrinogen-Rezeptor-Antagoniste
DE69822856D1 (de) Aminoterminal verkürztes rantes als chemokin antagonist
HU913074D0 (en) Fibrinogenic receptor antagonists
DE69824031D1 (de) Cyclopenten derivate als motilin-rezeptor antagonist
BR9707733A (pt) Antagonistas de receptores muscarinicos oxa-e-tia-diazol
DE69127549T2 (de) 5h-dibenzo[a,d]cycloheptene als muscarinic-rezeptor-antagonist
FI951798A (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
DE69104481D1 (de) Imidazo[4,5-c]pyridine als paf antagonisten.
NO179550C (no) Tachykinin reseptorantagonister
DE69406425D1 (de) Trizyklische heterozyklische verbindungen als 5-ht4 rezeptorantagonisten
ATE157645T1 (de) 5h-dibenzo(a,d>cycloheptene als muscarinic- rezeptor-antagonist
FI943872A (fi) 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina
AU7856194A (en) N-benzoyl-4-oxy/thio-2-substituted piperidines as substance-p receptor antagonists
BR9408265A (pt) Antagonistas de receptor de c5a não tendo substancialmente nenhuma atividade de antagonista
DE69216466T2 (de) Substituierte 2,3-Dihydroperimidine, als Beständigkeitsmittel
AU7457691A (en) Device for securing articles to a wall, fence or post
FR2680534B1 (fr) Garde-corps a usage multiples.
DE69004455T2 (de) Alpha-adrenergene Rezeptor-Antagonisten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS INC. (N.D.GES.D. STAATES PENNSYLVANIA), GR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US